Leaders Forum at imec Captures Europe at an Inflection Point
In June, the campus of imec in Leuven, Belgium hosted the second annual Neurotech Leaders Forum at imec, bringing together executives, investors, researchers, and regulators from across Europe and the U.S. for two days of sessions spanning clinical translation, capital formation, regulatory strategy, and the emerging and converging frontiers of neurotechnology.
HGNS Vendors Plan Response to Plunging Stock Valuations
The neuromodulation market for treating obstructive sleep apnea is currently experiencing a transitional rough patch, though its long-term market potential remains robust. Nominally represented by Inspire Medical, Nyxoah, and LivaNova, the market has seen staggered timelines of adoption. Inspire has been commercializing its devices in the U.S. since 2014, whereas Nyxoah entered in 2025, and LivaNova is targeting a full market launch in the second half of 2027.